Therapeutic conduct in children attended in emergency room during the epidemic of influenza A H1N1
Main Article Content
Keywords
Influenza A virus, H1N1 subtype, Antiviral Agents, Anti-bacterial Agents, Drugs Prescriptions, Child
Abstract
Objective: to analyze the prescription of antiviral and antibiotic agents in children with upper airway infection (UAI) during Influenza H1N1 epidemic.
Methods: a cross-section study (01/04/2009 to 31/03/2010) was performed. We analyzed the antiviral and antibiotic agents’ prescription and its relation with the presence of the triad of symptom of suspicion (migraine, fever and cough) and the cost for attention (medicines and screening test).
Results: 838 children were attendance for UAI, 40.3 % with the suspicion triad. In 733 patients, the screening test were done with 155 positive results (120 had the triad). All patient with a positive result received oseltamivir. During the first five months of the epidemic, the medical prescriptions were: antibiotics 60-85 %, 0-7 % anti-viral and 20-30 % symptomatic drug´s. At the 6th at 8th months (peak of outbreak) antibiotics 35-70 %, anti-virals 20-25 % and 10-30 % symptomatic drug´s. At final months (9th to 11th) antimicrobials 65-80 %, antivirals 20-30 % and symptomatic 0-10 %. The cost for URI attention increased a 27 %.
Conclusions: medical prescription changed during the epidemic, with an increased in the anti-virals, especially for patients with high suspicion for influenza and positive screening test.
References
Low D. Reducing antibiotic use in influenza: challenges and rewards. Clin Microbiol Infect. 2008;14 (4):298-306.
Rothberg MB, Fisher D, Kelly B, Rose DN. Management of influenza symptoms in healthy children: cost-effectiveness of rapid testing and antiviral therapy. Arch Pediatr Adolesc Med. 2005; 159(11):1055-1062. Disponible en http://archpedi. ama-assn.org/cgi/reprint/159/11/1055
American Academy of Pediatrics Committee on Infectious Diseases. Antiviral therapy and prophylaxis for influenza in children. Pediatrics. 2007; 119(4):852-860. Disponible en http://pediatrics. aappublications.org/cgi/reprint/119/4/852
Friedman MJ, Attia MW. Clinical predictors of influenza in children. Arch Pediatr Adolesc Med. 2004;158(4):391-394. Disponible en http://archpedi.ama-assn.org/cgi/reprint/158/4/391
Jennings LC, Skopnik H, Burckhardt I, Hribar I, Del Piero L, Deichmann KA. Effect of rapid influenza testing on the clinical management of paediatric influenza. Influenza Other Respir Viruses. 2009;3(3):91-98.
Bonner AB, Monroe KW, Talley LI, Klasner AE, Kimberlin DW. Impact of the rapid diagnosis of influenza on physician decision-making and patient management in the pediatric emergency depart-ment: results of a randomized, prospective, controlled trial. Pediatrics. 2003;112(2):363-367. Disponible en http://pediatrics.aappublications.org/cgi/reprint/112/2/363
Mitamura K, Sugaya N. Diagnosis and treatment of influenza-clinical investigation on viral shedding in children with influenza. Uirusu. 2006;56(1):109-116.
Uyeki TM. Influenza diagnosis and treatment in children: a review of studies on clinically useful test and antiviral treatment for influenza. Pediatr Infect Dis J. 2003;22(2):164-177.
Pierron S, Haas H, Berlioz M, Ollier L, Albertini M. Impact of rapid influenza test during influenza epidemic in all febrile children less than 6 years old in a pediatric emergency department. Arch Pediatr. 2008;15(8):1283-1288.
Instituto Mexicano del seguro Social. Guía de práctica clínica, prevención, diagnóstico y tratamiento de la influenza A H1N1. México: Instituto Mexicano del seguro Social; 2009. Disponible en http://www.imss.gob.mx/NR/rdonlyres/037AA1E9-530E-4E8B-882F-F8B6EA1D3233/0/GPC_InfluenzaA H1N117092009.pdf
Shun-Shin M, Thompson W, Heneghan C, Perera R, Harnden A, Mant D. Neuraminidase inhibitors for treatment and prophylaxis of influenza in children: systematic review and meta-analysis of randomized controlled trials. BMJ. 2009;339:b3172. Disponible en http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2724601/pdf/bmj.b3172.pdf
Balfour HH Jr, Englund J. Antiviral drugs in pediatrics. Am J Dis Child. 1989;143(11):1307-1316.
Jofré L. Tratamiento y profilaxis de influenza estacional en niños. Neumol Pediatr. 2009;4(1):29-34. Disponible en http://www.neumologia-pediatrica. cl/pdf/200941/200941.pdf#page=35
Echeverría-Zuno S, Mejía-Aranguré J, Mar-Obeso J, Grajales-Muñiz C, Robles-Pérez E, González-León M, et al. Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis. Lancet. 2009;374:2072-2079.
Laguna-Torres VA, Benavides JG. Infection and death from influenza AH1N1virus in Mexico. Lancet. 2009;374(9707):2072-2079.